Inhibition of HIV and SIV infectivity by blockade of alpha-glucosidase activity
about
Comparative cellular processing of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp160 by the mammalian subtilisin/kexin-like convertasesInhibition of alpha-glucosidase I of the glycoprotein-processing enzymes by 6-O-butanoyl castanospermine (MDL 28,574) and its consequences in human immunodeficiency virus-infected T cellsReduction of globotriaosylceramide in Fabry disease mice by substrate deprivationStrain-specific antiviral activity of iminosugars against human influenza A virusesN-alkyl-3-decarboxy-3-hydroxymethylsiastatin B, a new family of glycosidase inhibitors of gem-diamine 1-N-iminosugars.Resistance of native, oligomeric envelope on simian immunodeficiency virus to digestion by glycosidases.Antiretroviral therapy: strategies beyond single-agent reverse transcriptase inhibition.Antiviral therapy for human immunodeficiency virus infectionsProcessing of the envelope glycoprotein gp160 in immunotoxin-resistant cell lines chronically infected with human immunodeficiency virus type 1.N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposureNovel therapeutic targets for the treatment of Fabry disease.The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding.Legitimate and illegitimate cleavage of human immunodeficiency virus glycoproteins by furin.In vitro modification of human immunodeficiency virus type 1 (HIV-1) infectivity by the U937 cells.
P2860
Q24534205-5425BDE2-7032-48E6-9B3B-0BC5ACCA6526Q28369132-00AD74F2-C2B4-4BDA-83C4-136A3A73B743Q28507844-81B253BE-01A3-4C5B-B8D8-94FCABF708C5Q30366818-C680AC52-2C57-45E7-926E-CD81AD256BF5Q30673022-1A250BF5-961B-4B01-A6F5-EF0801571031Q33827027-6FCABBCA-B23D-4979-A449-9962C27A29F6Q35325810-A6625031-15F2-43E5-958D-774AD776040AQ35366050-1EDA971A-E431-4DFA-AC3B-C9E6789F490CQ35851143-3BC280E6-4329-4436-82AF-DA3759AF3C01Q35870879-D2F6DC3E-DF2D-41C4-980E-CB732316C946Q35870903-A5E91913-00F8-4030-B634-CD3F025B6D44Q36822452-CE2EF454-6539-4E2B-BD8A-848EEFB04D4FQ39871743-54C59331-5F53-4511-B6E3-523080BFE1CAQ40045540-40A150DF-A62C-4F7F-A372-D8C70C4FCD5EQ41583785-A88F1A04-DE8B-4BE8-B780-610AFF703A96
P2860
Inhibition of HIV and SIV infectivity by blockade of alpha-glucosidase activity
description
1991 nî lūn-bûn
@nan
1991 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի մարտին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Inhibition of HIV and SIV infectivity by blockade of alpha-glucosidase activity
@ast
Inhibition of HIV and SIV infectivity by blockade of alpha-glucosidase activity
@en
Inhibition of HIV and SIV infectivity by blockade of alpha-glucosidase activity
@nl
type
label
Inhibition of HIV and SIV infectivity by blockade of alpha-glucosidase activity
@ast
Inhibition of HIV and SIV infectivity by blockade of alpha-glucosidase activity
@en
Inhibition of HIV and SIV infectivity by blockade of alpha-glucosidase activity
@nl
prefLabel
Inhibition of HIV and SIV infectivity by blockade of alpha-glucosidase activity
@ast
Inhibition of HIV and SIV infectivity by blockade of alpha-glucosidase activity
@en
Inhibition of HIV and SIV infectivity by blockade of alpha-glucosidase activity
@nl
P2093
P1433
P1476
Inhibition of HIV and SIV infectivity by blockade of alpha-glucosidase activity
@en
P2093
N vander Heyden
P304
P356
10.1016/0042-6822(91)90483-R
P407
P577
1991-03-01T00:00:00Z